BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)
Bristol-Myers Squibb(US:BMY) Newsfilter·2023-12-27 03:43RayzeBio被Bristol Myers Squibb收购 - RayzeBio将被Bristol Myers Squibb以约41亿美元的全现金交易收购[2] Gracell被AstraZeneca收购 - Gracell将被AstraZeneca以每股2美元的现金收购[3] Daseke被TFI International收购 - Daseke将被TFI International以约11亿美元的全现金交易收购[5] Karuna Therapeutics被Bristol Myers Squibb收购 - Karuna Therapeutics将被Bristol Myers Squibb以约140亿美元的全现金交易收购[6]